1. Home
  2. DRTS vs ACV Comparison

DRTS vs ACV Comparison

Compare DRTS & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRTS
  • ACV
  • Stock Information
  • Founded
  • DRTS 2015
  • ACV 2015
  • Country
  • DRTS Israel
  • ACV United States
  • Employees
  • DRTS N/A
  • ACV N/A
  • Industry
  • DRTS Medical/Dental Instruments
  • ACV Finance/Investors Services
  • Sector
  • DRTS Health Care
  • ACV Finance
  • Exchange
  • DRTS Nasdaq
  • ACV Nasdaq
  • Market Cap
  • DRTS 252.8M
  • ACV 229.2M
  • IPO Year
  • DRTS N/A
  • ACV N/A
  • Fundamental
  • Price
  • DRTS $3.12
  • ACV $22.90
  • Analyst Decision
  • DRTS Strong Buy
  • ACV
  • Analyst Count
  • DRTS 2
  • ACV 0
  • Target Price
  • DRTS $8.00
  • ACV N/A
  • AVG Volume (30 Days)
  • DRTS 43.2K
  • ACV 38.8K
  • Earning Date
  • DRTS 08-13-2025
  • ACV 01-01-0001
  • Dividend Yield
  • DRTS N/A
  • ACV 9.20%
  • EPS Growth
  • DRTS N/A
  • ACV N/A
  • EPS
  • DRTS N/A
  • ACV N/A
  • Revenue
  • DRTS N/A
  • ACV N/A
  • Revenue This Year
  • DRTS N/A
  • ACV N/A
  • Revenue Next Year
  • DRTS N/A
  • ACV N/A
  • P/E Ratio
  • DRTS N/A
  • ACV N/A
  • Revenue Growth
  • DRTS N/A
  • ACV N/A
  • 52 Week Low
  • DRTS $1.93
  • ACV $16.82
  • 52 Week High
  • DRTS $4.39
  • ACV $23.74
  • Technical
  • Relative Strength Index (RSI)
  • DRTS 59.34
  • ACV 74.28
  • Support Level
  • DRTS $2.91
  • ACV $21.82
  • Resistance Level
  • DRTS $3.20
  • ACV $22.05
  • Average True Range (ATR)
  • DRTS 0.16
  • ACV 0.24
  • MACD
  • DRTS -0.00
  • ACV 0.03
  • Stochastic Oscillator
  • DRTS 68.70
  • ACV 88.15

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

Share on Social Networks: